Biologic Therapy for Refractory Immune Checkpoint Inhibitor Colitis

Immune checkpoint inhibitors (ICI) are treatments for several cancer types. Pathogenesis of ICI-induced colitis is not yet clearly explained as it can be disguised as another form such as inflammatory bowel disease or IBD. Recent studies revealed that ICI-induced colitis is a unique form of colitis...

Descripción completa

Detalles Bibliográficos
Autores principales: Alorfi, Nasser M, Alourfi, Mansour Marzouq
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9362776/
https://www.ncbi.nlm.nih.gov/pubmed/35957978
http://dx.doi.org/10.2147/BTT.S367675

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9362776/
https://www.ncbi.nlm.nih.gov/pubmed/35957978
http://dx.doi.org/10.2147/BTT.S367675

Ejemplares similares